Feng, Xiaodong_ Xie, Hong-Guang - Applying pharmacogenomics in therapeutics-CRC Press (2016)

Principles of Pharmacogenetic Biotechnology and Testing in Clinical Practice
47
Gardner, K. R., F. X. Brennan, R. Scott, and J. Lombard. 2014. The potential utility of pharmacogenetic
testing in psychiatry. Psychiatry J 2014: 730956.
Gogol-Doring, A., and W. Chen. 2012. An overview of the analysis of next generation
sequencing data. Methods Mol Biol 802: 249–257.
Haga, S. B., and N. M. LaPointe. 2013. The potential impact of pharmacogenetic testing on
medication adherence. Pharmacogenomics J 13: 481–483.
Harakalova, M., M. Mokry, B. Hrdlickova, I. Renkens, K. Duran, et al. 2011. Multiplexed
array-based and in-solution genomic enrichment for flexible and cost-effective targeted
next-generation sequencing. Nat Protoc 6: 1870–1886.
Heyries, K. A., C. Tropini, M. Vaninsberghe, C. Doolin, O. I. Petriv, et al. 2011. Megapixel
digital PCR. Nat Methods 8: 649–651.
Hinds, D. A., L. L. Stuve, G. B. Nilsen, E. Halperin, E. Eskin, et al. 2005. Whole-genome patterns
of common DNA variation in three human populations. Science 307: 1072–1079.
Hindson, C. M., J. R. Chevillet, H. A. Briggs, E. N. Gallichotte, I. K. Ruf, et al. 2013. Absolute
quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 10:
1003–1005.
Holland, P. M., R. D. Abramson, R. Watson, and D. H. Gelfand. 1991. Detection of specific
polymerase chain reaction product by utilizing the 5′–3′ exonuclease activity of
Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 88: 7276–7280.
Iafrate, A. J., L. Feuk, M. N. Rivera, M. L. Listewnik, P. K. Donahoe, et al. 2004. Detection
of large-scale variation in the human genome. Nat Genet 36: 949–951.
Ingelman-Sundberg, M. 2004. Pharmacogenetics of cytochrome P450 and its applications
in drug therapy: The past, present and future. Trends Pharmacol Sci 25: 193–200.
Johnson, J. A. 2003. Pharmacogenetics: Potential for individualized drug therapy through
genetics. Trends Genet 19: 660–666.
Jones, P. A., and S. B. Baylin. 2002. The fundamental role of epigenetic events in cancer.
Nat Rev Genet 3: 415–428.
Kalinina, O., I. Lebedeva, J. Brown, and J. Silver. 1997. Nanoliter scale PCR with TaqMan
detection. Nucleic Acids Res 25: 1999–2004.
Kalow, W. 1956. Familial incidence of low pseudocholinesterase level. Lancet 268: 576–577.
Kalow, W. 1982. Ethnic differences in drug metabolism. Clin Pharmacokinet 7: 373–400.
Kalow, W., B. K. Tang, D. Kadar, L. Endrenyi, and F. Y. Chan. 1979. A method for studying
drug metabolism in populations: Racial differences in amobarbital metabolism. Clin
Pharmacol Ther 26: 766–776.
Karch, S. B. 2007. Changing times: DNA resequencing and the “nearly normal autopsy.”
J Forensic Leg Med 14: 389–397.
Kidd, J. M., G. M. Cooper, W. F. Donahue, H. S. Hayden, N. Sampas, et al. 2008. Mapping
and sequencing of structural variation from eight human genomes. Nature 453: 56–64.
Kirchheiner, J., H. Schmidt, M. Tzvetkov, J. T. Keulen, J. Lotsch, et al. 2007. Pharmacokinetics
of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6
duplication. Pharmacogenomics J 7: 257–265.
Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, et al. 2001. Initial sequencing
and analysis of the human genome. Nature 409: 860–921.
Lashkari, D. A., J. L. DeRisi, J. H. McCusker, A. F. Namath, C. Gentile, et al. 1997. Yeast
microarrays for genome wide parallel genetic and gene expression analysis. Proc Natl
Acad Sci U S A 94: 13057–13062.
Lee, S. Y., and H. L. McLeod. 2011. Pharmacogenetic tests in cancer chemotherapy: What
physicians should know for clinical application. J Pathol 223: 15–27.
Levy, K. D., B. S. Decker, J. S. Carpenter, D. A. Flockhart, P. R. Dexter, et al. 2014.
Prerequisites to implementing a pharmacogenomics program in a large health-care
system. Clin Pharmacol Ther 96: 307–309.